Skip to content
10-K

Annual Report

MEDICUS PHARMA LTD. MDCX MDCXW

0001062993-26-001606

← back to feed
Filed
Mar 25, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 17, 2026 39.36M sh
Shares Diluted FY 2025 · Dec 31, 2025 17.28M sh
Shares Diluted FY 2025 · Dec 31, 2024 9.62M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$22.78M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$10.25M
Short Term Debt FY 2025 · Dec 31, 2025 $5.25M
Short Term Debt FY 2025 · Dec 31, 2024 $0
Cash And Equivalents FY 2025 · Dec 31, 2025 $8.71M
Cash And Equivalents FY 2025 · Dec 31, 2024 $4.16M
Stockholders Equity FY 2025 · Dec 31, 2025 −$67.55K
Stockholders Equity FY 2025 · Dec 31, 2024 $3.13M
Current Liabilities FY 2025 · Dec 31, 2025 $9.94M
Current Liabilities FY 2025 · Dec 31, 2024 $2.31M
Total Liabilities FY 2025 · Dec 31, 2025 $10.02M
Total Liabilities FY 2025 · Dec 31, 2024 $2.51M
Current Assets FY 2025 · Dec 31, 2025 $9.89M
Current Assets FY 2025 · Dec 31, 2024 $5.38M
Total Assets FY 2025 · Dec 31, 2025 $10.06M
Total Assets FY 2025 · Dec 31, 2024 $5.65M
Eps Diluted FY 2025 · Dec 31, 2025 −$2.74
Eps Diluted FY 2025 · Dec 31, 2024 −$1.16
Eps Basic FY 2025 · Dec 31, 2025 −$2.74
Eps Basic FY 2025 · Dec 31, 2024 −$1.16
Sga Expense FY 2025 · Dec 31, 2025 $17.92M
Sga Expense FY 2025 · Dec 31, 2024 $7.65M
Rd Expense FY 2025 · Dec 31, 2025 $7.72M
Rd Expense FY 2025 · Dec 31, 2024 $3.53M
Net Income FY 2025 · Dec 31, 2025 −$47.28M
Net Income FY 2025 · Dec 31, 2024 −$11.16M
Operating Income FY 2025 · Dec 31, 2025 −$34.36M
Operating Income FY 2025 · Dec 31, 2024 −$11.18M